Publications by authors named "Karl Welte"

Claim this Profile
T
Targeted inhibition of expression using adenine base editing to treat severe congenital neutropenia.
Betül Findik, Benjamin Dannenmann, Franka Bernhard, Masako Monika Kaufmann, Sandra Ammann, Karl Welte

Mol Ther Methods Clin Dev· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuning of G-CSFR signaling by de novo-designed agonists.
Timo Ullrich, Christoph Pollmann, Malte Ritter, Jérémy Haaf, Narges Aghaallaei, Karl Welte

Mol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and clinical characteristics of patients with Shwachman Diamond syndrome with special consideration of treatment with granulocyte-colony stimulating factor.
Sabine Mellor-Heineke, Julia Skokowa, Natali Gerschmann, Ekaterina Deordieva, Ivan Tesakov, Karl Welte

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAMPT-mediated deacetylation of HCLS1 protein promotes clonogenic growth of pediatric CML cells.
Bardia Samareh, Olga Klimenkova, Narges Aghaallaei, Lijuan Cheng, Andrew Zikic, Karl Welte

Exp Hematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flavopiridol restores granulopoiesis in experimental models of severe congenital neutropenia.
Masoud Nasri, Benjamin Dannenmann, Larissa Doll, Betül Findik, Franka Bernhard, Karl Welte

Mol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new severe congenital neutropenia syndrome associated with autosomal recessive COPZ1 mutations.
Natalia Borbaran Bravo, Ekaterina Deordieva, Larissa Doll, Mohammad ElGamacy, Benjamin Dannenmann, Karl Welte

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European guidelines on treatment and supportive measures in chronic neutropenias: A consensus between the European Hematology Association and the EuNet-INNOCHRON COST Action based on a systematic evidence review.
Francesca Fioredda, Michail Spanoudakis, Julia Skokowa, Hannah Tamary, Piero Farruggia, Karl Welte

Hemasphere· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forty years of human G-CSF: A short history in time.
Karl Welte

Br J Haematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Gene-Editing Approaches for Severe Congenital Neutropenia-Causing Mutations in the Gene.
Malte Ulrich Ritter, Masoud Nasri, Benjamin Dannenmann, Perihan Mir, Benjamin Secker, Karl Welte

CRISPR J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A JAGN1-associated severe congenital neutropenia zebrafish model revealed an altered G-CSFR signaling and UPR activation.
Larissa Doll, Karl Welte, Julia Skokowa, Baubak Bajoghli

Blood Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia.
Masoud Nasri, Malte U Ritter, Perihan Mir, Benjamin Dannenmann, Masako M Kaufmann, Karl Welte

Mol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential transcriptional control of hematopoiesis in congenital and cyclic neutropenia patients harboring mutations.
Alexander Zeidler, Natalia Borbaran-Bravo, Benjamin Dannenmann, Malte Ritter, Masoud Nasri, Karl Welte

Haematologica· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells.
Yun Xu, Masoud Nasri, Benjamin Dannenmann, Perihan Mir, Azadeh Zahabi, Karl Welte

Stem Cell Res Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia.
Benjamin Dannenmann, Maksim Klimiankou, Benedikt Oswald, Anna Solovyeva, Jehan Mardan, Karl Welte

Cell Stem Cell· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HAX1-related congenital neutropenia: Long-term observation in paediatric and adult patients enrolled in the European branch of the Severe Chronic Neutropenia International Registry (SCNIR).
Denys Pogozhykh, Deniz Yilmaz Karapinar, Maksim Klimiankou, Natali Gerschmann, Georg Ebetsberger-Dachs, Karl Welte

Br J Haematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action.
Francesca Fioredda, Julia Skokowa, Hannah Tamary, Michail Spanoudakis, Piero Farruggia, Karl Welte

Hemasphere· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34+ cells preceding leukemic transformation' <[Experimental Hematology, Volume 71, 2019;71:51-60]>.
Benjamin Dannenmann, Azadeh Zahabi, Perihan Mir, Benedikt Oswald, Regine Bernhard, Karl Welte

Exp Hematol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A topological refactoring design strategy yields highly stable granulopoietic proteins.
Julia Skokowa, Birte Hernandez Alvarez, Murray Coles, Malte Ritter, Masoud Nasri, Karl Welte

Nat Commun· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A unique role of p53 haploinsufficiency or loss in the development of acute myeloid leukemia with FLT3-ITD mutation.
Min Yang, Zengkai Pan, Kezhi Huang, Guntram Büsche, Hongyun Liu, Karl Welte

Leukemia· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia.
Benjamin Dannenmann, Maksim Klimiankou, Benedikt Oswald, Anna Solovyeva, Jehan Mardan, Karl Welte

Cell Stem Cell· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicing.
Christoph Schürch, Thorsten Schaefer, Joëlle S Müller, Pauline Hanns, Marlon Arnone, Karl Welte

Blood· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotinamide (vitamin B3) treatment improves response to G-CSF in severe congenital neutropenia patients.
Ekaterina Deordieva, Oksana Shvets, Kirill Voronin, Alexei Maschan, Karl Welte

Br J Haematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells.
Yun Xu, Masoud Nasri, Benjamin Dannenmann, Perihan Mir, Azadeh Zahabi, Karl Welte

Stem Cell Res Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of novel granulopoietic proteins by topological rescaffolding.
Birte Hernandez Alvarez, Julia Skokowa, Murray Coles, Perihan Mir, Masoud Nasri, Karl Welte

PLoS Biol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cooperating, congenital neutropenia-associated Csf3r and Runx1 mutations activate pro-inflammatory signaling and inhibit myeloid differentiation of mouse HSPCs.
Malte Ritter, Maksim Klimiankou, Olga Klimenkova, Axel Schambach, Dirk Hoffmann, Karl Welte

Ann Hematol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis